Clitoridectomy, Excision, Infibulation- Female Circumcision Ritual and Its Consequences for Women's Health
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Status of the Crusade to Eradicate Female Genital Mutilation: a Comparative Analysis of Laws and Programs in the United States and Egypt, the Elizabeth A
Penn State International Law Review Volume 22 Article 11 Number 4 Penn State International Law Review 5-1-2004 Status of the Crusade to Eradicate Female Genital Mutilation: A Comparative Analysis of Laws and Programs in the United States and Egypt, The Elizabeth A. Syer Follow this and additional works at: http://elibrary.law.psu.edu/psilr Recommended Citation Syer, Elizabeth A. (2004) "Status of the Crusade to Eradicate Female Genital Mutilation: A Comparative Analysis of Laws and Programs in the United States and Egypt, The," Penn State International Law Review: Vol. 22: No. 4, Article 11. Available at: http://elibrary.law.psu.edu/psilr/vol22/iss4/11 This Comment is brought to you for free and open access by Penn State Law eLibrary. It has been accepted for inclusion in Penn State International Law Review by an authorized administrator of Penn State Law eLibrary. For more information, please contact [email protected]. I Comment I The Status of the Crusade to Eradicate Female Genital Mutilation: A Comparative Analysis of Laws and Programs in the United States and Egypt Elizabeth A. Syer* John F. Kennedy once said, "[O]ur progress as a nation can be no swifter than our progress in education. The human mind is our fundamental resource."' This notion still holds true today. Throughout the course of history, education has proven to be an explosive technique in battling against human rights violations. 2 Female Genital Mutilation (hereinafter "FGM") or female circumcision is a battle that must be fought using education as its cannon;3 only then will this cruel and * Elizabeth A. -
FGM in Canada
Compiled by Patricia Huston MD, MPH Scientific Communications International, Inc for the Federal Interdepartmental Working Group on FGM. Copies of this report are available from: Women's Health Bureau Health Canada [email protected] The Canadian Women's Health Network 203-419 Graham Avenue Winnipeg, Manitoba R3C 0M3 fax: (204)989-2355 The opinions expressed in this report are not necessarily those of the Government of Canada or any of the other organizations represented. Dedication This report is dedicated to all the women in the world who have undergone FGM and to all the people who are helping them live with and reverse this procedure. This report is part of the ongoing commitment of Canadians and the Government of Canada to stop this practice in Canada and to improve the health and well-being of affected women and their communities. Executive Summary Female genital mutilation (FGM), or the ritual excision of part or all of the external female genitalia, is an ancient cultural practice that occurs around the world today, especially in Africa. With recent immigration to Canada of peoples from Somalia, Ethiopia and Eritrea, Sudan and Nigeria, women who have undergone this practice are now increasingly living in Canada. It is firmly believed by the people who practise it, that FGM improves feminine hygiene, that it will help eliminate disease and it is thought to be the only way to preserve family honour, a girl's virginity and her marriageability. FGM has a number of important adverse health effects including risks of infection and excessive bleeding (often performed when a girl is pre-pubertal). -
Gynecologic Oncology
Cancer: Gynecologic Oncology FirstHealth Oncology offers a board certified gynecologic oncologist for the evaluation and management of gynecological cancer. As part of the FirstHealth Outpatient Cancer Center a full range of services including education, support services, case management, symptom management and dietary services are available. Gynecologic Oncology Services Available • Management of gynecologic cancers to include ovarian, fallopian tube, Michael Sundborg, M.D. Brian Burgess, D.O. primary peritoneal carcinoma, uterine/endometrial, cervical, vulvar, and vaginal cancers • Advanced surgical management for complex pelvic disease • Administration and management of chemotherapy for gynecological malignancies • Long term surveillance for gynecological malignancies MI • Advanced minimally invasive surgery;DLAND Robotic Surgery RO • Palliative Supportive Care AIRPORT AD RO • Genetic counseling and managementAD for hereditary ovarian, breast and uterine cancers Adara Maness, PA-C • Management for suspected gynecological cancers to include pelvic masses • Management of gynecologic cancer patients via tumor board • Management of pre-invasive disease of the genital tract to include cervix, vulva and vagina MIDLAND RO • Management of gestational trophoblastic diseases to include persistent / invasive molar pregnancies,AD chorio carcinoma, placental site trophoblastic diseases E IEMORE DRIVE AV GE DRIV GE H ROAD SOUT PA PAGE N ROAD NORTH PAGE Main Phone Number: (910) 715-6740 Address: 35 Memorial Drive Entrance 4 Pinehurst, NC 28374 REGIONAL DRIVE LE RC AL DRIVE MEMORI REGIONAL CI E V I R D E G A L IL V T RS FI EPIC: REF 29 1 974-60-21 Cancer: Gynecologic Oncology To refer patients for a consult, call (910) 715-8684. Please give the patient a copy of this form to bring to his/her appointment. -
Creating a New Paradigm in Gynecologic Cancer Care: Policy Proposals for Delivery, Quality and Reimbursement
Creating a New Paradigm in Gynecologic Cancer Care: Policy Proposals for Delivery, Quality and Reimbursement A Society of Gynecologic Oncology White Paper February 2013 Creating a New Paradigm in Gynecologic Cancer Care February 2013 Table of Contents Executive Summary 3 I. Introduction 6 Purpose of the Report Key Questions II. What is the Society of Gynecologic Oncology? 7 III. Delivering High Quality Gynecologic Cancer Care 9 Weaknesses in Current Delivery Systems Proposed Solutions for Optimizing Delivery Systems Resources Needed to Implement the Care Team Model Ultimate Outcome of the Proposed Care Team Delivery Model IV. Defining High Quality Gynecologic Cancer Care 18 Weaknesses in Current Quality Systems Proposed Solutions and Resources Required to Optimize Quality Measures and Improvement What will be the Ultimate Outcome of this Proposed Quality Improvement System? V. Payment Systems for Delivery of High Quality 24 Gynecologic Cancer Care Weaknesses in Current Payment System Proposed Solutions to Optimize Payment Systems Resources Needed to Facilitate a Demonstration Project Followed by Implementation of New Payment Systems Resources Needed to Facilitate a Demonstration Project Followed by Implementation of New Payment Systems VI. Summary 35 References 37 Appendix 39 Practice Summit Participants 40 Page 2 Creating a New Paradigm in Gynecologic Cancer Care February 2013 Executive Summary The increasing financial burden of cancer care negatively impacts the U.S. health care system, our nation’s economy, and individuals’ quality of life. More importantly, it contributes significantly to premature death. The current health policy environment for cancer care is built upon a system that often rewards volume and intensity of therapy rather than proper coordination and quality of care. -
Wellness & Preventive Health
wellness & preventive health Cancer treatments may increase your chance of developing other health problems years after you have completed treatment. The purpose of this self care plan is to inform you about what steps you can take to maintain good health after cancer treatment. Keep in mind that every person treated for cancer is different and that these recommendations are not intended to be a substitute for the advice of a doctor or other health care professional. Please use these recommendations to talk with your health care provider about an appropriate follow up care plan for you. Surveillance for Your Cancer Breast Cancer Screening Cancer surveillance visit with medical provider that is For more information, see the ACS document Breast focused on detecting signs of recurrence of your cancer. Cancer: Early Detection. For additional information, visit www.livestrong.org or www.cancer.org/cancer/breast-cancer/screening-tests-and- www.cancer.net/patient/Survivorship early-detection.html Frequency depends on type and stage of cancer you had. • Yearly mammograms starting at age 40-49, and (If you had a higher risk cancer, you may be seen more continuing yearly as long as a woman is in good health. often). Your doctor has provided you with a personalized • Clinical breast exam (CBE), performed by a health care cancer treatment summary and survivorship care plan. If professional, every 1-3 years for women aged 25-39, you need another copy, ask your doctor. and every year for women 40 and older. • A monthly breast self-exam (BSE) is a good way to General Cancer Screening for Women monitor breast health. -
Rotation in Gynecologic Oncology
Department of Obstetrics and Gynecology Externships for Visiting Medical Students Rotation in Gynecologic Oncology Externs choosing this elective rotation will function as student interns in the Division of Gynecologic Oncology. The Gynecologic Oncology Team cares for a diverse, multiethnic population of both county and private patients. The inpatient care takes place entirely on campus at Parkland Memorial Hospital and the William P. Clements Jr. University Hospital. The Gyn Onc Team consists of five faculty members, four gynecologic oncology fellows (two clinical and two laboratory fellows), and six Parkland residents. Externs will be integrated into this team to provide care for all women diagnosed with gynecologic malignancies at our institutions. During your time here, you will have both inpatient and outpatient experiences at Parkland Hospital as well as Clements University Hospital and the Harold C. Simmons Comprehensive Cancer Center. As an extern, you will scrub and assist in surgical cases and follow patients postoperatively. You will have a role in in-house consultations as well as medical admissions and will also have the opportunity to share your knowledge during daily ward rounds. Other tasks will include performing H&Ps on new clinic patients as well as seeing follow-up patients and learning chemotherapy options and side effects. You will also attend the resident didactic conferences and the gyn onc conferences. Our busy clinical service provides comprehensive clinical and surgical exposure for visiting students and offers the opportunity to learn about the diagnosis and treatment of gynecological cancers. This rotation is intended to provide an intense clinical experience with an emphasis on teaching. -
Female Genital Cutting: Breaking the Silence, Enabling Change
Synthesis Paper Female Genital Cutting: Breaking the Silence, Enabling Change Julia M. Masterson Julie Hanson Swanson Photos courtesy of: Julia Masterson Design: Manu Badlani Copyright© 2000 International Center for Research on Women and The Centre for Development and Population Activities Female Genital Cutting: Breaking the Silence, Enabling Change Julia M. Masterson Julie Hanson Swanson Table of Contents Preface ................................................................................................................................................. 3 Acknowledgments .............................................................................................................................. 4 Executive Summary............................................................................................................................ 5 Introduction ........................................................................................................................................ 7 What is FGC? ....................................................................................................................................... 8 Applying Global Rights at the Local Level: Three Approaches to Ending FGC ........................... 12 Enabling Change: Lessons and Recommendations....................................................................... 23 Next Steps .......................................................................................................................................... 31 Appendix .......................................................................................................................................... -
Medicalisation of Female Genital Mutilation/Cutting in Sudan: Shifts in Types and Providers
MEDICALISATION OF FEMALE GENITAL MUTILATION/CUTTING IN SUDAN: SHIFTS IN TYPES AND PROVIDERS October 2018 MEDICALISATION OF FEMALE GENITAL MUTILATION/CUTTING IN SUDAN: SHIFTS IN TYPES AND PROVIDERS NAFISA BEDRI HUDA SHERFI GHADA RODWAN SARA ELHADI WAFA ELAMIN GENDER AND REPRODUCTIVE HEALTH AND RIGHTS RESOURCE AND ADVOCACY CENTER AHFAD UNIVERSITY FOR WOMEN OCTOBER 2018 The Evidence to End FGM/C: Research to Help Girls and Women Thrive generates evidence to inform and influence investments, policies, and programmes for ending female genital mutilation/cutting in different contexts. Evidence to End FGM/C is led by the Population Council, Nairobi in partnership with the Africa Coordinating Centre for the Abandonment of Female Genital Mutilation/Cutting (ACCAF), Kenya; the Gender and Reproductive Health and Rights Resource and Advocacy Center (GRACE), Sudan; the Global Research and Advocacy Group (GRAG), Senegal; Population Council, Nigeria; Population Council, Egypt; Population Council, Ethiopia; MannionDaniels, Ltd. (MD); Population Reference Bureau (PRB); University of California, San Diego (Dr. Gerry Mackie); and University of Washington, Seattle (Prof. Bettina Shell-Duncan). The Population Council confronts critical health and development issues—from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programmes, -
Violence Against Women in Africa: a Situational Analysis
United Nations Economic Commission for Africa African Centre for Gender and Social Development (ACGSD) VIOLENCE AGAINST WOMEN IN AFRICA: A SITUATIONAL ANALYSIS Table of Contents Background Methodology Common Abbreviations Situation Analysis of Africa Algeria Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo Cote D’Ivoire Djibouti Democratic Republic of Congo Egypt Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Bissau Guinea Kenya Lesotho Liberia Libya Madagascar Malawi Mali Mauritania Mauritius Morocco Mozambique Namibia Niger Nigeria Rwanda Sao Tome and Principe Senegal Seychelles Sierra Leone Somalia South Africa Sudan Swaziland Tanzania Togo Tunisia Uganda Zambia Zimbabwe Background Violence against women is perhaps the most widespread and socially tolerated of human rights violations, cutting across borders, race, class, ethnicity and religion. The impact of gender-based violence (GBV) is devastating. The individual women who are victims of such violence often experience life-long emotional distress, mental health problems and poor reproductive health, as well as being at higher risk of acquiring HIV and intensive long-term users of health services. In addition, the cost to women, their children, families and communities is a significant obstacle to reducing poverty, achieving gender equality and ensuring a peaceful transition for post-conflict societies. This, in conjunction with the mental and physical health implications of gender-based violence, impacts on a state or region’s ability to develop and construct a stable, productive society, or reconstruct a country in the wake of conflict. Gender-based violence in Africa, as elsewhere in the world, is a complex issue that has as its root the structural inequalities between men and women that result in the persistence of power differentials between the sexes. -
How Culture Is Affecting Women's Health
Canadian Open Nursing and Midwifery Journal Vol. 1, No. 1, May 2016, pp. 1-13 http://crpub.com/Journals.php Open Access Open Access Research article How Culture is Affecting Women’s Health Angela Bedard, RN, BScN E-mail: [email protected] This work is licensed under a Creative Commons Attribution 4.0 International License ______________________________________________ Abstract Women’s health and the importance placed on it has been an ongoing global issue for many years. The laws of basic human rights for some reason have left women in a very vulnerably and unhealth state which is directly caused by certain societal standards, cultural practices, and religious beliefs. Women’s health and life’s value in certain areas of the world are not as highly regarded as that of a man. Some of the women’s health violations that are having a large effect on women’s health today are: female genital mutilation, gavage, eating disorders, and female feticid. These violations have arisen from partrichial religious favoritism, societal pressures that have been established through media and law, and ideologies surrounding family honor. In countries like North Amerca across to Asia, traditions and the value on women are causing serious global health issues that are burdening the health care system and further more increasing the amount of preventable diseases and deaths accounted for every year. In health care it is important to identify these challenges women are facing globally and how organizations can provide a safer and healthier future for women worldwide. Education is the most effective way to promote health and prevent the reoccurence of current health issues women are facing today. -
Female Genital Mutilation De-Infibulation
ETHICS/EDUCATION with the most significant morbidity and mortality. Type 3 FGM is Female genital mutilation experienced by about 10% of all affected women. fi de-in bulation: antenatal Type 4: This includes all other harmful procedures to the female genitalia for non-medical purposes. E.g. Pricking, piercing, or intrapartum? scratching etc. There are no health benefits with FGM. There are immediate Sushama Gupta and lifelong health effects including, obstetric, sexual, psycho- Pallavi Latthe social, and economic impacts associated with FGM. Obstetric complications are: Difficulty in vaginal examination and catheterisation Abstract Prolonged and Obstructed labour Perineal tears Women who have had female genital mutilation (FGM) often experi- A high cesarean section rate due to difficulty in fetal ence adverse short and long term health effects. Owing to increasing monitoring and lack of adequately trained obstetric staff international migration FGM has become a global concern. Health pro- Increased incidence of PPH fessionals involved in the care of these women need to be aware of the Increased still birth and early neonatal death rates complications that it may present during labour as well as the sensi- Increased neonatal morbidity from hypoxia and brain tivity of the matter. This review summarises the studies available look- damage ing into the ideal time for deinfibulation. Keywords deinfibulation; female genital mutilation; FGM Deinfibulation Deinfibulation refers to the practice of surgically opening the Introduction sealed vaginal opening in a woman who has been infibulated. It has been shown to improve health and well-being as well as FGM is defined as all procedures that intentionally alter or obstetric outcomes. -
1 the Influence of Chemotherapy-Induced Peripheral
The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors ABSTRACT Objective: The aim of this observational study was to investigate correlations between long-term chemotherapy-induced peripheral neurotoxicity (CIPN) and quality of life (QOL) (physical well-being, social well-being, emotional well-being [EWB], and functional well-being [FWB]) among survivors of gynecologic cancer (GC). Methods: We aimed to assess the correlation of QOL and long-term CIPN with the temporal change in recurrence-free GC survival. Questionnaire responses and clinical data of 259 GC survivors were collected and assessed according to treatment received. The χ2 test was used to determine the significance of correlations. Results: Of 165 evaluable patients treated by chemotherapy, 36 patients (21.8%) developed CIPN of Common Toxicity Criteria for Adverse Events Grade ≥1 during the study. CIPN had significantly improved over time in the domain of FWB at ≥61 months after the end of chemotherapy (post-treatment4) among GC survivors (p=0.003). Furthermore, CIPN treated by more than 6 courses of the paclitaxel and carboplatin 1 (TC) regimen among GC survivors showed significant improvement over time in the EWB domain at 25–60 months and ≥61 months after the end of chemotherapy (post-treatment3 and 4) (p=0.037 and p=0.023) and in FWB at post-treatment4 (p<0.001). Conclusions: Emotional and functional domains of CIPN improved over time among GC survivors treated by more than 6 courses of the TC regimen. Based on these results, further research is required to identify additional preventative or curative approaches.